Oppenheimer thinks investors have not to fully appreciated International Business Machine 's new software product focus. The investment firm initiated shares of the...
DeepSeek's rise is the catalyst that will prompt global investors to allocate more toward Chinese stocks, even as economic worries persist, analysts predict....
The sell-off in Regeneron Pharmaceuticals presents an opportunity for investors to buy the stock on the cheap, according to Leerink Partners. Analyst David...
Electing a pro-cryptocurrency president was more than most investors ever thought possible. Almost three months after the election, however, the initial euphoria is...
After earnings sent some well-known companies diverging in Friday's session, Jessica Inskip, director of investor research at StockBrokers.com, has ideas on how to...